Loading…
Lobbying Spend
—
Filings
20
Firms Hired
2
Active Period
2016–2020
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
American Health Care Act of 2017
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Public Law 115-52, the FDA Reauthorization Act
Client expense: — · Firm income: $30,000
Matched citations: HR 1628
Protect Medical Innovation Act of 2018
2017 · fourth_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Public Law 115-52, the FDA Reauthorization Act
Client expense: — · Firm income: $30,000
Matched citations: HR 184
American Health Care Act of 2017
2017 · third_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Public Law 115-52, the FDA Reauthorization Act
Client expense: — · Firm income: $30,000
Matched citations: HR 1628
Protect Medical Innovation Act of 2018
2017 · third_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Public Law 115-52, the FDA Reauthorization Act
Client expense: — · Firm income: $30,000
Matched citations: HR 184
American Health Care Act of 2017
2017 · second_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Policy issues related to medical device user fee reauthorization
Client expense: — · Firm income: $30,000
Matched citations: HR 1628
Protect Medical Innovation Act of 2018
2017 · second_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Policy issues related to medical device user fee reauthorization
Client expense: — · Firm income: $30,000
Matched citations: HR 184
American Health Care Act of 2017
2017 · first_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Policy issues related to medical device user fee reauthorization
Client expense: — · Firm income: $30,000
Matched citations: HR 1628
Protect Medical Innovation Act of 2018
2017 · first_quarter · Firm: BAKER & HOSTETLER LLP
Regulatory and payment issues relating to medical technology manufacturers HR 184, Protect Medical Innovation Act HR 1628, the American Health Care Act Policy issues related to medical device user fee reauthorization
Client expense: — · Firm income: $30,000
Matched citations: HR 184
H.R. 6, the "21st Century Cures Act," specifically those sections relating to regulatory and reimbursement policies affecting the medical technology industry.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 6
Source: Senate LDA